Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

β2-Adrenoceptors and GRK2 as Potential Biomarkers in Patients With Chronic Pulmonary Regurgitation.

Rodriguez-Serrano M, Rueda J, Buendía F, Monto F, Aguero J, Osa A, Cano O, Martínez-Dolz L, D'Ocon P.

Front Pharmacol. 2019 Feb 19;10:93. doi: 10.3389/fphar.2019.00093. eCollection 2019.

2.

Dexamethasone Preconditioning in Cardiac Procedures Reduces Decreased Antithrombin Activity and Is Associated to Beneficial Outcomes: Role of Endothelium.

Muedra V, Moreno L, Rodilla V, Arce C, Montó F, Blázquez Á, Pérez P, D'Ocón P.

Front Pharmacol. 2018 Sep 25;9:1014. doi: 10.3389/fphar.2018.01014. eCollection 2018.

3.

Activation of α1A -adrenoceptors desensitizes the rat aorta response to phenylephrine through a neuronal NOS pathway, a mechanism lost with ageing.

Arce C, Vicente D, Segura V, Flacco N, Montó F, Almenar L, Agüero J, Rueda J, Jiménez-Altayó F, Vila E, Noguera MA, D'Ocon P, Ivorra MD.

Br J Pharmacol. 2017 Jul;174(13):2015-2030. doi: 10.1111/bph.13800. Epub 2017 May 10.

4.

Changes in the expression of α1B-adrenoceptor in peripheral mononuclear cells correlates with blood pressure and plasmatic homocysteine.

Oliver E, Montó F, Rovira E, Valldecabres C, Muedra V, D'Ocon P.

Biomed Pharmacother. 2017 Apr;88:721-727. doi: 10.1016/j.biopha.2017.01.061. Epub 2017 Jan 30.

PMID:
28152482
5.

Methodological Approach to Use Fresh and Cryopreserved Vessels as Tools to Analyze Pharmacological Modulation of the Angiogenic Growth.

Vicente D, Hernández B, Segura V, Pascual D, Fornaciari G, Monto F, Mirabet V, Montesinos MC, DʼOcon P.

J Cardiovasc Pharmacol. 2016 Sep;68(3):230-40. doi: 10.1097/FJC.0000000000000407.

PMID:
27631438
6.

β2- and β1-Adrenoceptor Expression Exhibits a Common Regulatory Pattern With GRK2 and GRK5 in Human and Animal Models of Cardiovascular Diseases.

Montó F, Oliver E, Vicente D, Buendía F, Rueda J, Agüero J, Almenar L, Valldecabres C, Rovira E, Muedra V, Noguera MA, Ivorra MD, DʼOcon P.

J Cardiovasc Pharmacol. 2015 Nov;66(5):478-86. doi: 10.1097/FJC.0000000000000299.

PMID:
26248277
7.

Glucocorticoids as modulators of expression and activity of Antithrombin (At): potential clinical relevance.

Barettino D, Masiá S, Montó F, Pérez P, D'Ocon P, Moreno L, Muedra V.

Thromb Res. 2015 Jan;135(1):183-91. doi: 10.1016/j.thromres.2014.10.026. Epub 2014 Nov 5.

PMID:
25466848
8.

Action of an extract from the seeds of Fraxinus excelsior L. on metabolic disorders in hypertensive and obese animal models.

Montó F, Arce C, Noguera MA, Ivorra MD, Flanagan J, Roller M, Issaly N, D'Ocon P.

Food Funct. 2014 Apr;5(4):786-96. doi: 10.1039/c3fo60539f.

PMID:
24573510
9.

The three α1-adrenoceptor subtypes show different spatio-temporal mechanisms of internalization and ERK1/2 phosphorylation.

Perez-Aso M, Segura V, Montó F, Barettino D, Noguera MA, Milligan G, D'Ocon P.

Biochim Biophys Acta. 2013 Oct;1833(10):2322-33. doi: 10.1016/j.bbamcr.2013.06.013. Epub 2013 Jun 21.

10.

Myocardial and lymphocytic expression of eNOS and nNOS before and after heart transplantation: relationship to clinical status.

Vicente D, Montó F, Oliver E, Buendía F, Rueda J, Agüero J, Almenar L, Barettino D, D'Ocon P.

Life Sci. 2013 Jul 30;93(2-3):108-15. doi: 10.1016/j.lfs.2013.05.025. Epub 2013 Jun 11.

PMID:
23770231
11.

Differences in the signaling pathways of α(1A)- and α(1B)-adrenoceptors are related to different endosomal targeting.

Segura V, Pérez-Aso M, Montó F, Carceller E, Noguera MA, Pediani J, Milligan G, McGrath IC, D'Ocon P.

PLoS One. 2013 May 24;8(5):e64996. doi: 10.1371/journal.pone.0064996. Print 2013.

12.

Different expression of adrenoceptors and GRKs in the human myocardium depends on heart failure etiology and correlates to clinical variables.

Montó F, Oliver E, Vicente D, Rueda J, Agüero J, Almenar L, Ivorra MD, Barettino D, D'Ocon P.

Am J Physiol Heart Circ Physiol. 2012 Aug 1;303(3):H368-76. doi: 10.1152/ajpheart.01061.2011. Epub 2012 Jun 8.

13.

Myocardial G protein receptor-coupled kinase expression correlates with functional parameters and clinical severity in advanced heart failure.

Agüero J, Almenar L, Montó F, Oliver E, Sánchez-Lázaro I, Vicente D, Martínez-Dolz L, D'Ocon P, Rueda J, Salvador A.

J Card Fail. 2012 Jan;18(1):53-61. doi: 10.1016/j.cardfail.2011.10.008. Epub 2011 Nov 25.

PMID:
22196842
14.

beta-Adrenoceptor and GRK3 expression in human lymphocytes is related to blood pressure and urinary albumin excretion.

Oliver E, Rovira E, Montó F, Valldecabres C, Julve R, Muedra V, Ruiz N, Barettino D, D'Ocon P.

J Hypertens. 2010 Jun;28(6):1281-9. doi: 10.1097/HJH.0b013e3283383564.

15.

Myocardial and peripheral lymphocytic transcriptomic dissociation of beta-adrenoceptors and G protein-coupled receptor kinases in heart transplantation.

Agüero J, Almenar L, D'Ocon P, Oliver E, Montó F, Rueda J, Vicente D, Martínez-Dolz L, Salvador A.

J Heart Lung Transplant. 2009 Nov;28(11):1166-71. doi: 10.1016/j.healun.2009.06.003. Epub 2009 Sep 26.

PMID:
19782607
16.

The impact of alpha1-adrenoceptors up-regulation accompanied by the impairment of beta-adrenergic vasodilatation in hypertension.

Oliver E, Martí D, Montó F, Flacco N, Moreno L, Barettino D, Ivorra MD, D'Ocon P.

J Pharmacol Exp Ther. 2009 Mar;328(3):982-90. doi: 10.1124/jpet.108.146043. Epub 2008 Dec 5. Erratum in: J Pharmacol Exp Ther. 2010 Aug;334(2):679.

PMID:
19060223
17.

Correlation between beta-adrenoceptors and G-protein-coupled receptor kinases in pretransplantation heart failure.

Agüero J, Almenar L, D'Ocon P, Oliver E, Montó F, Moro J, Castelló A, Rueda J, Martínez-Dolz L, Sánchez-Lazaro I, Montero JA.

Transplant Proc. 2008 Nov;40(9):3014-6. doi: 10.1016/j.transproceed.2008.09.011.

PMID:
19010176

Supplemental Content

Support Center